Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation

Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS chemical neuroscience 2016-11, Vol.7 (11), p.1531-1542
Hauptverfasser: Vonder Haar, Cole, Lam, Frederick C.W, Adams, Wendy K, Riparip, Lara-Kirstie, Kaur, Sukhbir, Muthukrishna, Michael, Rosi, Susanna, Winstanley, Catharine A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1542
container_issue 11
container_start_page 1531
container_title ACS chemical neuroscience
container_volume 7
creator Vonder Haar, Cole
Lam, Frederick C.W
Adams, Wendy K
Riparip, Lara-Kirstie
Kaur, Sukhbir
Muthukrishna, Michael
Rosi, Susanna
Winstanley, Catharine A
description Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury.
doi_str_mv 10.1021/acschemneuro.6b00166
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9487719</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1847884637</sourcerecordid><originalsourceid>FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</originalsourceid><addsrcrecordid>eNp9UU2P0zAQtRCIXQr_ACEfuWSxU-frglQCC5UqQLCcrUkyaVzFdrCdRf15_DMctazKhZNHM--9eeNHyEvObjhL-RtofTugNjg7e5M3jPE8f0SueSXKpODV-vFFfUWeeX9gLK9YmT8lV2mRpZkQxTX5feusCTDSOwezhqBa-s6BMnRrDrM70lh9g-BpDbNHT3fW7JMd-KDMnm71BMppNHG-MPQ0jx5pHQWdjYoDBLpxSN-rvkcXYQrG8Ui_o_EqqHukwdKvAzgNrQ0DOphwjgY8BdPRjfe2VRCwo79UGGg9RKPR3eflXmX6EfRi15rn5EkPce-L87siP24_3NWfkt2Xj9t6s0tAiCokkGcouqxqBAPBGgFtV6Yii900x57xruuyPOW8hI5VBbKmzxrsI6IR_dJdr8jbk-40Nxq7Nt7jYJSTUxrcUVpQ8t-JUYPc23sZQyiWEFbk9VnA2Z8z-iC18i2OIxi0s5e8FEVZinxdRKg4QVtnvXfYP6zhTC7py8v05Tn9SHt1afGB9DfuCGAnQKTLg52diT_2f80_77fG0Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1847884637</pqid></control><display><type>article</type><title>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Vonder Haar, Cole ; Lam, Frederick C.W ; Adams, Wendy K ; Riparip, Lara-Kirstie ; Kaur, Sukhbir ; Muthukrishna, Michael ; Rosi, Susanna ; Winstanley, Catharine A</creator><creatorcontrib>Vonder Haar, Cole ; Lam, Frederick C.W ; Adams, Wendy K ; Riparip, Lara-Kirstie ; Kaur, Sukhbir ; Muthukrishna, Michael ; Rosi, Susanna ; Winstanley, Catharine A</creatorcontrib><description>Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury.</description><identifier>ISSN: 1948-7193</identifier><identifier>EISSN: 1948-7193</identifier><identifier>DOI: 10.1021/acschemneuro.6b00166</identifier><identifier>PMID: 27525447</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Acute Disease ; Adrenergic Uptake Inhibitors - pharmacology ; Amantadine - pharmacology ; Amphetamine - pharmacology ; Animals ; Atomoxetine Hydrochloride - pharmacology ; Brain Injuries, Traumatic - complications ; Brain Injuries, Traumatic - drug therapy ; Brain Injuries, Traumatic - physiopathology ; Brain Injuries, Traumatic - psychology ; Central Nervous System Stimulants - pharmacology ; Chronic Disease ; Disease Models, Animal ; Disease Progression ; Disruptive, Impulse Control, and Conduct Disorders - drug therapy ; Disruptive, Impulse Control, and Conduct Disorders - etiology ; Disruptive, Impulse Control, and Conduct Disorders - pathology ; Disruptive, Impulse Control, and Conduct Disorders - physiopathology ; Dopamine Agents - pharmacology ; Frontal Lobe - drug effects ; Frontal Lobe - immunology ; Frontal Lobe - injuries ; Frontal Lobe - pathology ; Male ; Motor Activity - drug effects ; Motor Activity - physiology ; Neuroimmunomodulation - drug effects ; Neuroimmunomodulation - physiology ; Rats, Long-Evans ; Severity of Illness Index</subject><ispartof>ACS chemical neuroscience, 2016-11, Vol.7 (11), p.1531-1542</ispartof><rights>Copyright © 2016 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</citedby><cites>FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acschemneuro.6b00166$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acschemneuro.6b00166$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,780,784,885,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27525447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vonder Haar, Cole</creatorcontrib><creatorcontrib>Lam, Frederick C.W</creatorcontrib><creatorcontrib>Adams, Wendy K</creatorcontrib><creatorcontrib>Riparip, Lara-Kirstie</creatorcontrib><creatorcontrib>Kaur, Sukhbir</creatorcontrib><creatorcontrib>Muthukrishna, Michael</creatorcontrib><creatorcontrib>Rosi, Susanna</creatorcontrib><creatorcontrib>Winstanley, Catharine A</creatorcontrib><title>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</title><title>ACS chemical neuroscience</title><addtitle>ACS Chem. Neurosci</addtitle><description>Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury.</description><subject>Acute Disease</subject><subject>Adrenergic Uptake Inhibitors - pharmacology</subject><subject>Amantadine - pharmacology</subject><subject>Amphetamine - pharmacology</subject><subject>Animals</subject><subject>Atomoxetine Hydrochloride - pharmacology</subject><subject>Brain Injuries, Traumatic - complications</subject><subject>Brain Injuries, Traumatic - drug therapy</subject><subject>Brain Injuries, Traumatic - physiopathology</subject><subject>Brain Injuries, Traumatic - psychology</subject><subject>Central Nervous System Stimulants - pharmacology</subject><subject>Chronic Disease</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - drug therapy</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - etiology</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - pathology</subject><subject>Disruptive, Impulse Control, and Conduct Disorders - physiopathology</subject><subject>Dopamine Agents - pharmacology</subject><subject>Frontal Lobe - drug effects</subject><subject>Frontal Lobe - immunology</subject><subject>Frontal Lobe - injuries</subject><subject>Frontal Lobe - pathology</subject><subject>Male</subject><subject>Motor Activity - drug effects</subject><subject>Motor Activity - physiology</subject><subject>Neuroimmunomodulation - drug effects</subject><subject>Neuroimmunomodulation - physiology</subject><subject>Rats, Long-Evans</subject><subject>Severity of Illness Index</subject><issn>1948-7193</issn><issn>1948-7193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU2P0zAQtRCIXQr_ACEfuWSxU-frglQCC5UqQLCcrUkyaVzFdrCdRf15_DMctazKhZNHM--9eeNHyEvObjhL-RtofTugNjg7e5M3jPE8f0SueSXKpODV-vFFfUWeeX9gLK9YmT8lV2mRpZkQxTX5feusCTDSOwezhqBa-s6BMnRrDrM70lh9g-BpDbNHT3fW7JMd-KDMnm71BMppNHG-MPQ0jx5pHQWdjYoDBLpxSN-rvkcXYQrG8Ui_o_EqqHukwdKvAzgNrQ0DOphwjgY8BdPRjfe2VRCwo79UGGg9RKPR3eflXmX6EfRi15rn5EkPce-L87siP24_3NWfkt2Xj9t6s0tAiCokkGcouqxqBAPBGgFtV6Yii900x57xruuyPOW8hI5VBbKmzxrsI6IR_dJdr8jbk-40Nxq7Nt7jYJSTUxrcUVpQ8t-JUYPc23sZQyiWEFbk9VnA2Z8z-iC18i2OIxi0s5e8FEVZinxdRKg4QVtnvXfYP6zhTC7py8v05Tn9SHt1afGB9DfuCGAnQKTLg52diT_2f80_77fG0Q</recordid><startdate>20161116</startdate><enddate>20161116</enddate><creator>Vonder Haar, Cole</creator><creator>Lam, Frederick C.W</creator><creator>Adams, Wendy K</creator><creator>Riparip, Lara-Kirstie</creator><creator>Kaur, Sukhbir</creator><creator>Muthukrishna, Michael</creator><creator>Rosi, Susanna</creator><creator>Winstanley, Catharine A</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20161116</creationdate><title>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</title><author>Vonder Haar, Cole ; Lam, Frederick C.W ; Adams, Wendy K ; Riparip, Lara-Kirstie ; Kaur, Sukhbir ; Muthukrishna, Michael ; Rosi, Susanna ; Winstanley, Catharine A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a449t-a65e4d59b40a40b4acd824565e26ef01ddd562118ad097e0bf5bef245b4f118a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute Disease</topic><topic>Adrenergic Uptake Inhibitors - pharmacology</topic><topic>Amantadine - pharmacology</topic><topic>Amphetamine - pharmacology</topic><topic>Animals</topic><topic>Atomoxetine Hydrochloride - pharmacology</topic><topic>Brain Injuries, Traumatic - complications</topic><topic>Brain Injuries, Traumatic - drug therapy</topic><topic>Brain Injuries, Traumatic - physiopathology</topic><topic>Brain Injuries, Traumatic - psychology</topic><topic>Central Nervous System Stimulants - pharmacology</topic><topic>Chronic Disease</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - drug therapy</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - etiology</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - pathology</topic><topic>Disruptive, Impulse Control, and Conduct Disorders - physiopathology</topic><topic>Dopamine Agents - pharmacology</topic><topic>Frontal Lobe - drug effects</topic><topic>Frontal Lobe - immunology</topic><topic>Frontal Lobe - injuries</topic><topic>Frontal Lobe - pathology</topic><topic>Male</topic><topic>Motor Activity - drug effects</topic><topic>Motor Activity - physiology</topic><topic>Neuroimmunomodulation - drug effects</topic><topic>Neuroimmunomodulation - physiology</topic><topic>Rats, Long-Evans</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vonder Haar, Cole</creatorcontrib><creatorcontrib>Lam, Frederick C.W</creatorcontrib><creatorcontrib>Adams, Wendy K</creatorcontrib><creatorcontrib>Riparip, Lara-Kirstie</creatorcontrib><creatorcontrib>Kaur, Sukhbir</creatorcontrib><creatorcontrib>Muthukrishna, Michael</creatorcontrib><creatorcontrib>Rosi, Susanna</creatorcontrib><creatorcontrib>Winstanley, Catharine A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS chemical neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vonder Haar, Cole</au><au>Lam, Frederick C.W</au><au>Adams, Wendy K</au><au>Riparip, Lara-Kirstie</au><au>Kaur, Sukhbir</au><au>Muthukrishna, Michael</au><au>Rosi, Susanna</au><au>Winstanley, Catharine A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation</atitle><jtitle>ACS chemical neuroscience</jtitle><addtitle>ACS Chem. Neurosci</addtitle><date>2016-11-16</date><risdate>2016</risdate><volume>7</volume><issue>11</issue><spage>1531</spage><epage>1542</epage><pages>1531-1542</pages><issn>1948-7193</issn><eissn>1948-7193</eissn><abstract>Traumatic brain injury (TBI) affects millions yearly, and is increasingly associated with chronic neuropsychiatric symptoms. We assessed the long-term effects of different bilateral frontal controlled cortical impact injury severities (mild, moderate, and severe) on the five-choice serial reaction time task, a paradigm with relatively independent measurements of attention, motor impulsivity, and motivation. Moderately- and severely injured animals exhibited impairments across all cognitive domains that were still evident 14 weeks postinjury, while mild-injured animals only demonstrated persistent deficits in impulse control. However, recovery of function varied considerably between subjects such that some showed no impairment (“TBI-resilient”), some demonstrated initial deficits that recovered (“TBI-vulnerable”), and some never recovered (“chronically-impaired”). Three clinically relevant treatments for impulse-control or TBI, amphetamine, atomoxetine, and amantadine, were assessed for efficacy in treating injury-induced deficits. Susceptibility to TBI affected the response to pharmacological challenge with amphetamine. Whereas sham and TBI-resilient animals showed characteristic impairments in impulse control at higher doses, amphetamine had the opposite effect in chronically impaired rats, improving task performance. In contrast, atomoxetine and amantadine reduced premature responding but increased omissions, suggesting psychomotor slowing. Analysis of brain tissue revealed that generalized neuroinflammation was associated with impulsivity even when accounting for the degree of brain damage. This is one of the first studies to characterize psychiatric-like symptoms in experimental TBI. Our data highlight the importance of testing pharmacotherapies in TBI models in order to predict efficacy, and suggest that neuroinflammation may represent a treatment target for impulse control problems following injury.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>27525447</pmid><doi>10.1021/acschemneuro.6b00166</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-7193
ispartof ACS chemical neuroscience, 2016-11, Vol.7 (11), p.1531-1542
issn 1948-7193
1948-7193
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9487719
source MEDLINE; American Chemical Society Journals
subjects Acute Disease
Adrenergic Uptake Inhibitors - pharmacology
Amantadine - pharmacology
Amphetamine - pharmacology
Animals
Atomoxetine Hydrochloride - pharmacology
Brain Injuries, Traumatic - complications
Brain Injuries, Traumatic - drug therapy
Brain Injuries, Traumatic - physiopathology
Brain Injuries, Traumatic - psychology
Central Nervous System Stimulants - pharmacology
Chronic Disease
Disease Models, Animal
Disease Progression
Disruptive, Impulse Control, and Conduct Disorders - drug therapy
Disruptive, Impulse Control, and Conduct Disorders - etiology
Disruptive, Impulse Control, and Conduct Disorders - pathology
Disruptive, Impulse Control, and Conduct Disorders - physiopathology
Dopamine Agents - pharmacology
Frontal Lobe - drug effects
Frontal Lobe - immunology
Frontal Lobe - injuries
Frontal Lobe - pathology
Male
Motor Activity - drug effects
Motor Activity - physiology
Neuroimmunomodulation - drug effects
Neuroimmunomodulation - physiology
Rats, Long-Evans
Severity of Illness Index
title Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A00%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frontal%20Traumatic%20Brain%20Injury%20in%20Rats%20Causes%20Long-Lasting%20Impairments%20in%20Impulse%20Control%20That%20Are%20Differentially%20Sensitive%20to%20Pharmacotherapeutics%20and%20Associated%20with%20Chronic%20Neuroinflammation&rft.jtitle=ACS%20chemical%20neuroscience&rft.au=Vonder%20Haar,%20Cole&rft.date=2016-11-16&rft.volume=7&rft.issue=11&rft.spage=1531&rft.epage=1542&rft.pages=1531-1542&rft.issn=1948-7193&rft.eissn=1948-7193&rft_id=info:doi/10.1021/acschemneuro.6b00166&rft_dat=%3Cproquest_pubme%3E1847884637%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1847884637&rft_id=info:pmid/27525447&rfr_iscdi=true